Judith Leurs

542 total citations
12 papers, 400 citations indexed

About

Judith Leurs is a scholar working on Hematology, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Judith Leurs has authored 12 papers receiving a total of 400 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Hematology, 4 papers in Molecular Biology and 3 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Judith Leurs's work include Blood Coagulation and Thrombosis Mechanisms (6 papers), Peptidase Inhibition and Analysis (3 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (2 papers). Judith Leurs is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (6 papers), Peptidase Inhibition and Analysis (3 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (2 papers). Judith Leurs collaborates with scholars based in Belgium, Netherlands and Sweden. Judith Leurs's co-authors include Dirk Hendriks, Viveca Nerme, K. Schatteman, Robert Verkerk, Simon Scharpé, I. Juhan‐Vague, Miet Peeters, Els Brouwers, Bonno N. Bouma and Paul Declerck and has published in prestigious journals such as Analytical Biochemistry, Arteriosclerosis Thrombosis and Vascular Biology and Thrombosis and Haemostasis.

In The Last Decade

Judith Leurs

12 papers receiving 384 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Judith Leurs Belgium	11	274	103	102	84	73	12	400
Isabell Seitz Germany	10	163 0.6×	184 1.8×	257 2.5×	103 1.2×	46 0.6×	11	554
Michael J. Mellott United States	11	232 0.8×	165 1.6×	42 0.4×	57 0.7×	44 0.6×	13	381
C.M. van den Hoogen United States	7	219 0.8×	35 0.3×	111 1.1×	205 2.4×	76 1.0×	12	406
J.P. Farcet France	9	143 0.5×	43 0.4×	76 0.7×	31 0.4×	31 0.4×	10	399
Simone Schuhler France	11	280 1.0×	74 0.7×	65 0.6×	46 0.5×	52 0.7×	13	375
Carl Högberg Sweden	12	184 0.7×	60 0.6×	159 1.6×	46 0.5×	20 0.3×	18	466
R.J. Olds United Kingdom	15	685 2.5×	130 1.3×	207 2.0×	190 2.3×	37 0.5×	24	851
Tsutomu Hamuro Japan	12	227 0.8×	201 2.0×	75 0.7×	55 0.7×	20 0.3×	16	470
André Brizard France	12	322 1.2×	113 1.1×	102 1.0×	16 0.2×	16 0.2×	29	627
Fulvio Brema Italy	12	86 0.3×	47 0.5×	79 0.8×	136 1.6×	67 0.9×	36	562

Countries citing papers authored by Judith Leurs

Since Specialization

Citations

This map shows the geographic impact of Judith Leurs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Judith Leurs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Judith Leurs more than expected).

Fields of papers citing papers by Judith Leurs

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Judith Leurs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Judith Leurs. The network helps show where Judith Leurs may publish in the future.

Co-authorship network of co-authors of Judith Leurs

This figure shows the co-authorship network connecting the top 25 collaborators of Judith Leurs. A scholar is included among the top collaborators of Judith Leurs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Judith Leurs. Judith Leurs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Nesheim, Michael E., Judith Leurs, & Dirk Hendriks. (2006). Thrombin-activatable fibrinolysis inhibitor aka procarboxypeptidase U. 381–394. 2 indexed citations

Leurs, Judith & Dirk Hendriks. (2005). Carboxypeptidase U (TAFIa): a metallocarboxypeptidase with a distinct role in haemostasis and a possible risk factor for thrombotic disease. Thrombosis and Haemostasis. 94(9). 471–487. 62 indexed citations

Willemse, Johan, Judith Leurs, Robert Verkerk, & Dirk Hendriks. (2005). Development of a fast kinetic method for the determination of carboxypeptidase U (TAFIa) using C-terminal arginine containing peptides as substrate. Analytical Biochemistry. 340(1). 106–112. 25 indexed citations

Leurs, Judith, et al.. (2004). Carboxypeptidase U (TAFIa) prevents lysis from proceeding into the propagation phase through a threshold‐dependent mechanism. Journal of Thrombosis and Haemostasis. 2(3). 416–423. 89 indexed citations

Vogelvang, Tatjana E., Judith Leurs, Marius J. van der Mooren, et al.. (2004). Raloxifene reduces procarboxypeptidase U, an antifibrinolytic marker. A 2-year randomized, placebo-controlled study in healthy early postmenopausal women. Menopause The Journal of The North American Menopause Society. 11(1). 110–115. 11 indexed citations

Leurs, Judith, et al.. (2003). Different mechanisms contribute to the biphasic pattern of carboxypeptidase U (TAFIa) generation during in vitro clot lysis in human plasma. Thrombosis and Haemostasis. 89(2). 264–271. 37 indexed citations

Gils, Ann, Marie‐Christine Alessi, Els Brouwers, et al.. (2003). Development of a Genotype 325–Specific proCPU/TAFI ELISA. Arteriosclerosis Thrombosis and Vascular Biology. 23(6). 1122–1127. 73 indexed citations

Post, Marinka S., Dirk Hendriks, Marius J. van der Mooren, et al.. (2002). Oral oestradiol/trimegestone replacement reduces procarboxypeptidase U (TAFI): a randomized, placebo‐ controlled, 12‐week study in early postmenopausal women. Journal of Internal Medicine. 251(3). 245–251. 17 indexed citations

Abrahamsson, Tommy, Viveca Nerme, K. Schatteman, et al.. (2002). Local proCPU (TAFI) Activation during Thrombolytic Treatment in a Dog Model of Coronary Artery Thrombosis can be Inhibited with a Direct, Small Molecule Thrombin Inhibitor (Melagatran). Thrombosis and Haemostasis. 87(4). 557–562. 23 indexed citations

10.

Schatteman, K., et al.. (2001). Fast Homogeneous Assay for Plasma Procarboxypeptidase U. Clinical Chemistry and Laboratory Medicine (CCLM). 39(9). 806–10. 13 indexed citations

11.

Schatteman, K., Filip Goossens, Judith Leurs, et al.. (2001). arboxypeptidase U at the Interface Between Coagulation and Fibrinolysis. Clinical and Applied Thrombosis/Hemostasis. 7(2). 93–101. 10 indexed citations

12.

Strömqvist, Mats, K. Schatteman, Judith Leurs, et al.. (2001). Immunological Assay for the Determination of Procarboxypeptidase U Antigen Levels in Human Plasma. Thrombosis and Haemostasis. 85(1). 12–17. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact